Newsletter Subscribe

Enter your email address below and subscribe to our newsletter

Patient Education

Share your love

Ora and SERI Team Up for Ophthalmic Research

Contract Research Organization (CRO) Ora Inc. announced a new strategic partnership with the Singapore Eye Research Institute (SERI) to bolster support for early-stage innovators in ophthalmology. This collaboration is set to enhance the development of therapeutic candidates in various ocular-specific…

Lumibird Launches C.DIAG for Dry Eye Disease

Lumibird Medical has unveiled its latest innovation, the C.DIAG, marking a significant advancement in dry eye diagnostic technology. Integrated with AI algorithms, this new component of the C.SUITE is designed to enable the diagnosis, treatment, and education of dry eye…

Early Patching Shows Promise for Lazy Eye Treatment

A recent study conducted by experts from the University of Leicester sheds light on a potentially more effective treatment approach for children with amblyopia, commonly known as lazy eye. Published in The Lancet, the study challenges the conventional method of…

FDA Accepts Eluminex’s IND for DME Antibody

Eluminex Biosciences announced the acceptance of its EB-105 Investigational New Drug (IND) application by the FDA. This significant milestone marks a pivotal moment in the advancement of medical science, particularly in the realm of Diabetic Macular Edema (DME) treatment. EB-105:…

Emmecell Completes Dosing in Key Corneal Edema Trial

Emmetrope Ophthalmics, a leader in cell-based therapies for severe eye diseases, today announced the completion of the final dose administration in its U.S. clinical trial for EO2002, targeting the treatment of corneal edema. EO2002 Advances Toward Phase 3 This milestone…

RetiSpec, Topcon Collaborate on Eye-Based AI Diagnostic Tool

Topcon Healthcare has announced an investment in RetiSpec, marking the beginning of a collaboration aimed at commercializing RetiSpec’s innovative technology. This partnership intends to bridge the gap between neurology and eye care, potentially transforming how Alzheimer’s disease is detected and…

FDA Clears AEYE Health’s Autonomous AI for DR Screening

AEYE Health has received FDA clearance for its fully autonomous AI, making it the first to diagnose referable diabetic retinopathy using a handheld camera. The technology, known as AEYE Diagnostic Screening (AEYE-DS), was previously approved for use with a tabletop…

Inflammasome Therapeutics Begins GA Clinical Trial

Inflammasome Therapeutics has officially dosed the first patient in a pioneering clinical trial aimed at treating geographic atrophy (GA) resulting from age-related macular degeneration (AMD). This trial, a first-in-class study for a sustained release implant, is sponsored by the University…

Stay informed and not overwhelmed, subscribe now!